Document:

Amendment Two to the United Security Bancshares, Inc Non-Employee Directors'

 EXHIBIT 10.22B 
 AMENDMENT TWO 
 UNITED SECURITY BANCSHARES, INC. 

NON-EMPLOYEE DIRECTORS’ DEFERRED COMPENSATION PLAN 
 WITNESSETH: 
 WHEREAS, United Security Bancshares, Inc. (the
“Holding Company”) hereto established a nonqualified deferred compensation plan known as the United Security Bancshares, Inc. Non-Employee Directors’ Deferred Compensation Plan (the “Plan”); 

WHEREAS, the American Jobs Creation Act of 2004 created new Internal Revenue Code Section 409A (“Code
Section 409A”), which imposes documentary and operational requirements on non-qualified deferred compensation arrangements; 
 WHEREAS, amounts deferred under the Plan meet the definition of “nonqualified deferred compensation” as set forth in Code Section 409A; 

WHEREAS, Internal Revenue Service Notice 2010-6 provides additional guidance regarding the implementation of Code
Section 409A; and 
 WHEREAS, the Holding Company desires to amend the Plan, effective as of January 1, 2009,
to comply with the requirements of Code Section 409A pursuant to the guidance and relief provided under Internal Revenue Service Notice 2010-6. 
 NOW, THEREFORE, the Holding Company, in accordance with the provisions of the Plan pertaining to amendments thereof, hereby amends the Plan, effective as of January 1, 2009, as follows:

 1. Amend Section 5.2(b) by replacing “as soon as administratively feasible” with “within 90 days”.

 2. Amend Section 6.5(b) by replacing “as soon as administratively feasible” with “within 90 days”.

 3. All other terms, conditions, and provisions not herein modified shall remain in full force and effect. 

IN WITNESS WHEREOF, United Security Bancshares, Inc. has caused this Amendment Two to the United Security Bancshares, Inc.
Non-Employee Directors’ Deferred Compensation Plan to be executed its duly authorized officer as of the 30th day of December, 2010. 
  

			
	UNITED SECURITY BANCSHARES, INC.
		
	By:	 	 /s/ R. Terry Phillips

		
	Name:	 	 R. TERRY PHILLIPS

		
	Its:	 	 PRESIDENT AND CEOUnited Security Banchares, Inc. Summary of Directors' Fees

 EXHIBIT 10.23 
 United Security Bancshares, Inc. 
 Summary of Directors’ Fees,
effective May 20, 2010 
 Bancshares’ Board of Directors approved the following retainers and attendance fees
for board and committee meetings, effective May 20, 2010: 
 United Security Bancshares, Inc. 

 

			
	Retainers:	  	
		
	 Chairperson
	  	$1,350/month
		
	 Board Members
	  	$600/month
		
	Board Meeting Fees:	  	
		
	 Board Members
	  	$500/board meeting attended
		
	Committee Chairperson Fees:	  	
		
	 Chairperson of the Audit Committee, the Compensation Committee and the Nominating, Executive and Corporate Governance
Committee
	  	 $400/committee meeting attended

 First United Security Bank 
  

			
		
	Board Meeting Fees:	  	
		
	 Board Members
	  	 $400/month

 Each non-employee member of the committees of United Security Bancshares, Inc. and First United Security Bank receives $250/committee meeting attended. The Corporate Secretary receives $450/month, and the
Treasurer and Investment Officer each receive $300/month for board service in those capacities. 
 Additionally, any director who attends board
meetings or committee meetings held outside of the director’s county of residence is reimbursed for mileage for meetings attended. Directors attending special board meetings are paid an attendance fee and are reimbursed for mileage. 

Non-employee directors may elect to defer payment of all or any portion of their fees under the United Security Bancshares, Inc. Non-Employee
Directors’ Deferred Compensation Plan (the “Plan”). The Plan, which was ratified by shareholders at the annual meeting held on May 11, 2004, permits non-employee directors to invest their directors’ fees and to receive the
adjusted value of the deferred amounts in cash and/or shares of Bancshares’ common stock.Amendment to Employment Agreement with Dwight Weller

 Exhibit 10.2 
 AMENDMENT TO EMPLOYMENT AGREEMENT 
 THIS AMENDMENT
(““Amendment”) TO THE EMPLOYMENT AGREEMENT (“Agreement”) dated November 4, 1996 is made on this 28th day of December, 2008 (the “Effective Date”), by and between AVI BioPharma, Inc., an Oregon
corporation, with its principal office at 1 SW Columbia Street, Suite 1105, Portland, OR 97258 (“Company”), and Dwight Weller, Ph.D. (“Employee”). 
 RECITALS: 
 The Company has entered into an employment agreement with the
Employee. 
 Section 409A was added to the Internal Revenue Code of 1986 (“Section 409A”)
regulating “deferred compensation.” Treasury Regulations and IRS rulings issued under Section 409A recently became effective and to avoid adverse tax consequences such regulations and rulings require amendments to be made to
agreements that contain “deferred compensation” as defined under Section 409A. 
 The Agreement contains
provisions that may be impacted by Section 409A. 
 NOW, THEREFORE, in consideration of the mutual benefits contained
herein, the parties hereby agree to amend the Agreement as follows: 
 AMENDMENT TO AGREEMENT: 

1. Provisions of Agreement Effective. Except as specifically modified by this Amendment, the provisions of the Agreement are
unchanged and remain fully effective. This Amendment is part of the Agreement and from this date references to the Agreement will include this Amendment. 
 2. Compliance with Section 409A. It is the intention of the parties that no payment or entitlement pursuant to the Agreement will give rise to any adverse tax consequences to the Employee or
the Company with regard to Section 409A. This Amendment and the Agreement shall be interpreted to that end and consistent with that objective. The Company and the Employee shall, to the extent necessary to comply with Section 409A and
permitted thereunder, agree to act reasonably and in good faith to mutually reform the provisions of the Agreement to avoid the application of the additional tax and interest under Section 409A(a)(l)(B), provided that any such reformation
shall not require an additional financial obligation by the Company. 
 3. Delayed Payments for Specified Employees.
Notwithstanding any other provision in the Agreement, if the Employee is a “Specified Employee,” under Treasury Regulation Section 1.409A-1(i), on the date of termination, to the extent required by Section 409A no payment of any
“deferred compensation,” under Treasury Regulation Section 1.409A-1(b), shall be made to the Employee during the period from the date of termination until the six (6) month anniversary of the date of termination. If any payment
to the Employee is delayed pursuant to the foregoing sentence, such payment instead shall be made on the first business day 

  
 1 – AMENDMENT TO
EMPLOYMENT AGREEMENT 

 
following the expiration of such six (6) month period or, at such earlier date as allowed under Section 409A for events such as death, disability, unforeseeable emergency or any other
reason permitted under Section 409A. 
 IN WITNESS WHEREOF, the Company has caused this Amendment to he signed by its duly
authorized representative, and the Employee has hereunder set his/her name as of the date of this Amendment. 
  

									
	COMPANY:	 		 	AVI BioPharma, Inc.
					
		 		 		 	By:	 	/s/ Leslie Hudson
		 		 		 	Its:	 	President & CEO

  

					
			
	EMPLOYEE:	 		 	/s/ Dwight Weller
		 		 	Dwight Weller, Ph.D.

  
 2 – AMENDMENT TO
EMPLOYMENT AGREEMENTAmendment No. 2 to Employment Agreement with Dwight Weller

 Exhibit 10.3 
 AMENDMENT NO. 2 
 TO 

EMPLOYMENT AGREEMENT 
  

 
 This Amendment No. 2 to Employment Agreement (the “Amendment”) is entered into effective the 19th day of January, 2010 (the “Effective Date”) by and between AVI BioPharma, Inc., an Oregon
corporation (“Company”) and Dwight Weller, Ph.D. (“Employee”). 
 RECITALS 

A. Whereas, Company and Employee are parties to that certain Employment Agreement dated the 4th day of November, 1996, as amended by Amendment to Employment
Agreement entered into effective the 22nd day of December,
2008, copies of which are attached hereto as Exhibit A (the “Employment Agreement”). 
 B.
Whereas, the Company and the Employee desire to add a provision to the Employment Agreement related to Section 280G of the Internal Revenue Code of 1986, as amended.
 Now, therefore, in consideration of the representations, warranties and covenants contained herein, the Company and the Employee agree as follows: 

AGREEMENT 
  

	1.	Section 24 is hereby added to the Employment Agreement, and shall state in its entirety as follows: 

“24. Section 280G 
 (a) Except as provided below, the payments or benefits to which Employee will be entitled under Section 13 of the Agreement will be reduced to the extent necessary so that Employee
will not be liable for the federal excise tax (the “Excise Tax”) levied on certain “excess parachute payments” under section 4999 of the Internal Revenue Code of 1986, as amended (“Code”). 

(b) The limitation above will not apply if: 
 (1) the difference between 
 (A) the present value of all payments to which
Employee is entitled under Section 13 of the Agreement determined without regard to the limitation above, less 

 (B) the present value of all federal, state, and other income and excise taxes for
which Employee is liable as a result of such payments; exceeds 
 (2) the difference between 

(A) the present value of all payments to which Employee is entitled under Section 13 of the Agreement calculated as if
the limitation above applies, less 
 (B) the present value of all federal, state, and other income and excise taxes
for which Employee is liable as a result of such reduced payments. 
 (c) Present values will be determined using
the interest rate specified in section 280G of the Code and will be the present values as of the date on which Employee’s employment terminates (unless it is necessary to use a different date in order to avoid adverse
consequences under section 280G). 
 (d) As a result of the uncertainty in the application of Section 280G
and 4999 of the Code, it is possible that, despite the limitations on parachute payments provided in this Section 24, amounts may be paid or distributed by the Company to or for the benefit of the Employee under this Agreement or
otherwise which are treated as excess parachute payments. In the event that any payments received by the Employee are determined by the IRS to be subject to the Excise Tax, the Company shall pay the Employee as promptly as possible
following such determination (but in no event later than the end of the Employee’s taxable year in which the Employee remits the related taxes) an additional amount which may be necessary to reimburse the Employee on an after-tax
basis for any Excise Tax that may be imposed on such excess parachute payments and for any interest and penalties related to such Excise Tax that may be imposed by the IRS or a court. In addition, the Company shall indemnify and hold the
Employee harmless, on an after-tax basis, from and against any and all losses, costs, damages or expenses (including reasonable attorneys’ and accountants fees) arising out of the imposition on Employee of any Excise Tax.” 

 

	2.	In all other respects, the Employment Agreement shall remain unchanged and in full force and effect. 

[SIGNATURE PAGE FOLLOWS] 

  
 - 2 -

 IN WITNESS WHEREOF, the parties have executed this Amendment effective the date
first set forth above. 
  

									
	AVI BioPharma, Inc.	 		 	
					
	By:	 	/s/ Leslie Hudson	 		 		 	/s/ Dwight Weller
	Name:	 	Leslie Hudson, Ph.D.	 		 		 	Dwight Weller, Ph.D.
	Title:	 	Chief Executive Officer	 		 		 	

  
 - 3 -

 EXHIBIT A 
 Employment Agreement and Amendment No. 1 to Employment Agreement 

Previously Filed

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]